Asthma inhaler showdown: new combo vs. standard treatment
NCT ID NCT05735431
First seen Jan 05, 2026 · Last updated May 23, 2026 · Updated 20 times
Summary
This study aimed to compare a new inhaler combining formoterol and fluticasone with an existing inhaler (formoterol/budesonide) for people with moderate asthma. The goal was to see if the new inhaler worked just as well at controlling asthma over 12 weeks. However, the study was withdrawn before any participants were enrolled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATE ASTHMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Eurofarma Laboratorios S.A
São Paulo, 06696-000, Brazil
Conditions
Explore the condition pages connected to this study.